{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:43:57Z","timestamp":1785293037911,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115283","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T09:30:48Z","timestamp":1753695048000},"page":"115283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploring the phytomedicine properties of azadiradione against leishmaniasis: in silico and in vitro insights"],"prefix":"10.1016","volume":"163","author":[{"given":"Saravanan","family":"Vijayakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Vedika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritam Narayan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayakar","family":"Alti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2025.115283_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008254","article-title":"Kala-azar elimination in a highly-endemic district of Bihar, India: a success story","volume":"14","author":"Kumar","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2025.115283_bb0010","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1016\/S1473-3099(16)30140-2","article-title":"Elimination of visceral leishmaniasis on the Indian subcontinent","volume":"16","author":"Singh","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.62883","article-title":"Treatment of visceral leishmaniasis","volume":"2","author":"Moore","year":"2010","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115283_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.826287","article-title":"Impact of genetic diversity and genome plasticity of Leishmania spp. in treatment and the search for novel chemotherapeutic targets","volume":"12","author":"Santi","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115283_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010696","article-title":"The increasing incidence of visceral leishmaniasis relapse in South Sudan: a retrospective analysis of field patient data from 2001\u20132018","volume":"16","author":"Naylor-Leyland","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2025.115283_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2023.108688","article-title":"In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive\/sensitive Leishmania donovani promastigotes and intracellular amastigotes","volume":"257","author":"Kumar","year":"2024","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2025.115283_bb0035","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00436-010-1973-0","article-title":"Activity of the julocrotine, a glutarimide alkaloid from Croton pullei var. glabrior, on Leishmania (L.) amazonensis","volume":"107","author":"Guimar\u00e3es","year":"2010","journal-title":"Parasitol. Res."},{"issue":"12","key":"10.1016\/j.intimp.2025.115283_bb0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.phymed.2011.03.004","article-title":"Plant derived therapeutics for the treatment of Leishmaniasis","volume":"18","author":"Sen","year":"2011","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.intimp.2025.115283_bb0045","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.3390\/molecules171112771","article-title":"Medicinal plants: a source of anti-parasitic secondary metabolites","volume":"17","author":"Wink","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2025.115283_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exppara.2013.12.006","article-title":"Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis","volume":"137","author":"Sachdeva","year":"2014","journal-title":"Exp. Parasitol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115283_bb0055","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00436-022-07532-5","article-title":"In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferase","volume":"121","author":"Kant","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.intimp.2025.115283_bb0060","first-page":"1","article-title":"An insight into the potentially old-wonder molecule\u2014quercetin: the perspectives in foresee","volume":"9","author":"Rani","year":"2015","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.intimp.2025.115283_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-14-98","article-title":"Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7 \u03b2 ol, from Fumaria parviflora lam","volume":"14","author":"Jameel","year":"2014","journal-title":"BMC Complement. Altern. Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.115283_bb0070","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3109\/13880200903485729","article-title":"Screening of medicinal plants against Leishmania amazonensis","volume":"48","author":"Garc\u00eda","year":"2010","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.intimp.2025.115283_bb0075","first-page":"68","article-title":"In vitro antileishmanial activity of Pleumeria pudica leaf extracts on Leishmania donovani promastigotes","volume":"8","author":"Jaydeep Sarkar","year":"2013","journal-title":"Am-Euras. J. Sci. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115283_bb0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4161\/cbt.12.6.16850","article-title":"Anticancer biology of Azadirachta indica L (neem): a mini review","volume":"12","author":"Paul","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"17","key":"10.1016\/j.intimp.2025.115283_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0973-7847.156337","article-title":"Azadirachta indica: a herbal panacea in dentistry\u2013an update","volume":"9","author":"Lakshmi","year":"2015","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.intimp.2025.115283_bb0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2016.03.002","article-title":"Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases","volume":"40","author":"Patel","year":"2016","journal-title":"Semin. Cancer Biol."},{"issue":"23","key":"10.1016\/j.intimp.2025.115283_bb0095","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.2174\/0929867328666210121123037","article-title":"Ethnomedicinal plants for the management of diabetes worldwide: a systematic review","volume":"28","author":"Aumeeruddy","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1515\/jcim-2021-0009","article-title":"The anti-cancer properties of neem (Azadirachta indica) through its antioxidant activity in the liver: its pharmaceutics and toxic dosage forms. A literature review","volume":"19","author":"Iman","year":"2022","journal-title":"J. Complement. Integr. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115283_bb0105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jpp\/rgab098","article-title":"Azadirachta indica a. Juss (neem) against diabetes mellitus: a critical review on its phytochemistry, pharmacology, and toxicology","volume":"74","author":"Patil","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/2772434416666210604105251","article-title":"An insight into the dermatological applications of neem: a review on traditional and modern aspect","volume":"16","author":"Singh","year":"2021","journal-title":"Recent Adv. Anti-Infect. Drug Discov."},{"issue":"3","key":"10.1016\/j.intimp.2025.115283_bb0115","first-page":"280","article-title":"The protective effect of Azadirachta indica (neem) against metabolic syndrome: a review","volume":"24","author":"Yarmohammadi","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2025.115283_bb0120","first-page":"1336","article-title":"Biological activities and medicinal properties of neem (Azadirachta indica)","volume":"82","author":"Biswas","year":"2002","journal-title":"Curr. Sci."},{"key":"10.1016\/j.intimp.2025.115283_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exppara.2015.02.011","article-title":"In vitro and in vivo evaluation of anti-leishmanial and immunomodulatory activity of neem leaf extract in Leishmania donovani infection","volume":"153","author":"Dayakar","year":"2015","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115283_bb0130","first-page":"115","article-title":"Azadiradione: a multi-targets compound with new therapeutic approach","volume":"6","author":"Badria","year":"2018","journal-title":"Asian J. Phytomed. Clin. Res."},{"key":"10.1016\/j.intimp.2025.115283_bb0135","doi-asserted-by":"crossref","first-page":"A3.B.1","DOI":"10.1002\/0471142735.ima03bs111","article-title":"Trypan blue exclusion test of cell viability","volume":"111","author":"Strober","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115283_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.parint.2013.01.007","article-title":"An in vitro study of apoptotic like death in Leishmania donovani promastigotes by withanolides","volume":"62","author":"Chandrasekaran","year":"2013","journal-title":"Parasitol. Int."},{"issue":"3","key":"10.1016\/j.intimp.2025.115283_bb0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/ci2005862","article-title":"Identification of novel S-adenosyl-L-homocysteine hydrolase inhibitors through homology-model-based virtual screening, synthesis, and biological evaluation","volume":"52","author":"Khare","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.intimp.2025.115283_bb0150","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/pharmaceutics14081590","article-title":"Metabolic pathways of Leishmania parasite: source of pertinent drug targets and potent drug candidates","volume":"14","author":"Jain","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.115283_bb0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2018.02.010","article-title":"Recent progress in drug targets and inhibitors towards combating leishmaniasis","volume":"181","author":"Vijayakumar","year":"2018","journal-title":"Acta Trop."},{"issue":"6","key":"10.1016\/j.intimp.2025.115283_bb0160","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1080\/07391102.2018.1461135","article-title":"Structural, molecular motions, and free-energy landscape of Leishmania sterol-14\u03b1-demethylase wild type and drug resistant mutant: a comparative molecular dynamics study","volume":"37","author":"Vijayakumar","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"7","key":"10.1016\/j.intimp.2025.115283_bb0165","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00436-022-07532-5","article-title":"In silico screening, molecular dynamic simulations, and in vitro activity of selected natural compounds as an inhibitor of Leishmania donovani 3-mercaptopyruvate sulfurtransferase","volume":"121","author":"Kant","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.intimp.2025.115283_bb0170","series-title":"Harnessing computational methods for uncovering structural insights into Leishmania donovani 3-MST: implications for drug design and target specificity","author":"Ranjan","year":"2024"},{"issue":"10","key":"10.1016\/j.intimp.2025.115283_bb0175","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.intimp.2025.115283_bb0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2025.115283_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107381","article-title":"In silico and in vitro evaluation of the immunogenic potential of Leishmania donovani ascorbate peroxidase and its derived peptides","volume":"260","author":"Kumari","year":"2024","journal-title":"Acta Trop."},{"issue":"5","key":"10.1016\/j.intimp.2025.115283_bb0190","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4269\/ajtmh.2010.10-0171","article-title":"Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis","volume":"83","author":"Wortmann","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007173","article-title":"The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia\u2013a review and meta-analysis","volume":"13","author":"Pijpers","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115283_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trstmh.2006.02.005","article-title":"Unresponsiveness to AmBisome in some Sudanese patients with kala-azar","volume":"101","author":"Mueller","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"9","key":"10.1016\/j.intimp.2025.115283_bb0205","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/cid\/civ004","article-title":"Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations","volume":"60","author":"Monge-Maillo","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2025.115283_bb0210","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2025.115283_bb0215","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115283_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2020.100583","article-title":"Multiple relapses of visceral leishmaniasis in HIV co-infected patients: a case series from Ethiopia","volume":"92","author":"Mohammed","year":"2020","journal-title":"Curr. Ther. Res."},{"issue":"12","key":"10.1016\/j.intimp.2025.115283_bb0225","doi-asserted-by":"crossref","first-page":"826","DOI":"10.12980\/apjtd.7.2017D7-215","article-title":"Antileishmanial activity of medicinal plants from Africa: a review","volume":"7","author":"Et-Touys","year":"2017","journal-title":"Asian Pac. J. Trop. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115283_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment\u2014a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4067\/S0716-97602012000200002","article-title":"The cytotoxic and antileishmanial activity of extracts and fractions of leaves and fruits of Azadirachta indica (a. Juss.)","volume":"45","author":"Carneiro","year":"2012","journal-title":"Biol. Res."},{"key":"10.1016\/j.intimp.2025.115283_bb0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.sajb.2018.10.019","article-title":"Phytochemical analyses and pharmacological screening of neem oil","volume":"120","author":"Cesa","year":"2019","journal-title":"S. Afr. J. Bot."},{"issue":"21","key":"10.1016\/j.intimp.2025.115283_bb0245","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.3390\/molecules27217579","article-title":"Antileishmanial activities of medicinal herbs and phytochemicals in vitro and in vivo: an update for the years 2015 to 2021","volume":"27","author":"Hassan","year":"2022","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.intimp.2025.115283_bb0250","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.phymed.2008.05.004","article-title":"Antimalarial, antimycobacterial and cytotoxic limonoids from Chisocheton siamensis","volume":"15","author":"Maneerat","year":"2008","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0250-474X.54279","article-title":"Antibacterial activity of medicinal plants against pathogens causing complicated urinary tract infections","volume":"71","author":"Sharma","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115283_bb0260","first-page":"66","article-title":"Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture","volume":"16","author":"Rochanakij","year":"1985","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"issue":"11","key":"10.1016\/j.intimp.2025.115283_bb0265","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2174\/1389557523666230901105231","article-title":"The application of MD simulation to Lead identification, vaccine design, and structural studies in combat against Leishmaniasis-a review","volume":"24","author":"Vijayakumar","year":"2024","journal-title":"Mini-Rev. Med. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2025.115283_bb0270","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01766-19","article-title":"Leishmanicidal activity of an in silico-screened novel inhibitor against ascorbate peroxidase of Leishmania donovani","volume":"64","author":"Kashif","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"21","key":"10.1016\/j.intimp.2025.115283_bb0275","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.202422899","article-title":"Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum","volume":"99","author":"Wilkinson","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.intimp.2025.115283_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011271","article-title":"Ascorbate peroxidase from Leishmania major controls the virulence of infective stage of promastigotes by regulating oxidative stress","volume":"5","author":"Pal","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2025.115283_bb0285","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/AAC.02834-14","article-title":"Ascorbate peroxidase, a key molecule regulating amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"58","author":"Kumar","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.intimp.2025.115283_bb0290","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02429-16","article-title":"In vitro evaluation of antileishmanial activity of computationally screened compounds against ascorbate peroxidase to combat amphotericin B drug resistance","volume":"61","author":"Mansuri","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.intimp.2025.115283_bb0295","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00193-19","article-title":"Ascorbate-dependent peroxidase (APX) from Leishmania amazonensis is a reactive oxygen species-induced essential enzyme that regulates virulence","volume":"87","author":"Xiang","year":"2019","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0300","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molbiopara.2004.02.015","article-title":"Two linked genes of Leishmania infantum encode tryparedoxins localised to cytosol and mitochondrion","volume":"136","author":"Castro","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115283_bb0305","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0891-5849(02)01089-4","article-title":"Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum","volume":"33","author":"Castro","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0310","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2958.2008.06154.x","article-title":"Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence","volume":"68","author":"Iyer","year":"2008","journal-title":"Mol. Microbiol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115283_bb0315","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/molecules21081013","article-title":"Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines","volume":"21","author":"Pe\u00f1a-Mor\u00e1n","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.intimp.2025.115283_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8546-7-15","article-title":"Evaluation of the anticancer potential of six herbs against a hepatoma cell line","volume":"7","author":"Weerapreeyakul","year":"2012","journal-title":"Chin. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115283_bb0325","doi-asserted-by":"crossref","DOI":"10.5812\/ijcm.8633","article-title":"Selective cytotoxicity and apoptosis-induction of Cyrtopodion scabrum extract against digestive cancer cell lines","volume":"10","author":"Rashidi","year":"2017","journal-title":"Int. J. Cancer Manag."},{"key":"10.1016\/j.intimp.2025.115283_bb0330","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.podrm.2020.07.005","article-title":"Validation of in-vitro bioassay methods: application in herbal drug research","volume":"46","author":"Indrayanto","year":"2021","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115283_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282729","article-title":"Bioactive Azadirachta indica and Melia azedarach leaves extracts with anti-SARS-CoV-2 and antibacterial activities","volume":"18","author":"Hemdan","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115283_bb0340","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-94-007-7305-9_4","article-title":"Arginase in leishmania. Arginase in Leishmania","volume":"74","author":"da Silva","year":"2014","journal-title":"Subcell. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2025.115283_bb0345","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2249.2005.02768.x","article-title":"Dichotomy of protective cellular immune responses to human visceral leishmaniasis","volume":"140","author":"Khalil","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2025.115283_bb0350","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115283_bb0355","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","article-title":"Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells","volume":"177","author":"Manetti","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.115283_bb0360","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-308X(08)60208-0","article-title":"Immunology of leishmaniasis","volume":"32","author":"Liew","year":"1993","journal-title":"Adv. Parasitol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115283_bb0365","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nyl\u00e9n","year":"2007","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115283_bb0370","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/IAI.71.11.6453-6462.2003","article-title":"Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis","volume":"71","author":"Murray","year":"2003","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.intimp.2025.115283_bb0375","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.intimp.2025.115283_bb0380","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115283_bb0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cyto.2018.06.033","article-title":"Pro-inflammatory cytokine interleukin-1\u03b2 (IL-1\u03b2) controls Leishmania infection","volume":"112","author":"Patil","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2025.115283_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101431","article-title":"Serum profile of IL-1\u03b2 and IL-17 cytokines in patients with visceral leishmaniasis","volume":"69","author":"Babaloo","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2025.115283_bb0395","doi-asserted-by":"crossref","DOI":"10.1038\/sj.jid.5700309","article-title":"Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections","volume":"126","author":"Kostka","year":"2006","journal-title":"J. Invest. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:14:19Z","timestamp":1757913259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925012731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":79,"alternative-id":["S1567576925012731"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115283","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the phytomedicine properties of azadiradione against leishmaniasis: in silico and in vitro insights","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115283"}}